Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine
Clinical trial NCT04384367 · COMPLETED
Trial details
- NCT number
- NCT04384367
- Sponsor
- Eurofarma Laboratorios S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2024-10-30
- Enrollment
- 2068
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.